4. INTRODUCTION
Periodontal disease comprises a group of inflammatory
conditions of the supporting tissues of the teeth that are
caused by bacteria.
In 1 mm3 of dental plaque
weighing approximately 1 mg
more than 108 bacteria
5. World Workshop in Periodontology (Consensus Report
1996) designated
A.actinomycetemcomitans
Porphyromonas gingivalis
Tannerella forsythia
7. Bacterium melaninogenicum- 1921
Bacterium melaninogenicus- 1939
asaccharolyticus
B melaninogenicus
intermediusmelaninogenicus
B. loescheii B. denticola
1970
1982
Prevotella
Melaninogenicus
1988, 1990
Prevotella
Loescheii
1988, 1990
Prevotella
Denticola
1988, 1990
Holdeman & Moore
8. Bacterium melaninogenicum- 1921
Bacterium melaninogenicus- 1939
asaccharolyticus
B. intermedius-1983
intermediusmelaninogenicus
1970
Prevotella
Intermedia
1988, 1990
Holdeman & Moore
9. Bacterium melaninogenicum- 1921
Bacterium melaninogenicus- 1939
asaccharolyticus
B. asaccharolyticus-1977
intermediusmelaninogenicus
B. gingivalis (oral) B. asaccharolyticus
(non-oral)
1970
1980
Porphyromonas
gingivalis
1988
Porphyromonas
asaccharolyticus
1988
Holdeman & Moore
Shah & Hardie and
Coykendall et al
10. Genus PORPHYROMONAS
Gram-negative, Obligately anaerobic, Nonfermentative, non-
sporeforming, nonmotile rods
Purple pigment in “black-pigmented” colonies
Porphyromonas asaccharolytica (Gut)
Porphyromonas gingivalis “of the gums”
Porphyromonas endodontalis “within a tooth”
14. ORAL ECOLOGY & TRANSMISSION
Natural habitat:
Highest frequency—periodontal pocket
(Asikainen et al 1997)
Supragingival plaque and oral mucosal surfaces
(muller et al 1993)
Saliva (van Winkelhoff et al 1986)
Pharynx (van steenberg et al 1993)
16. Subgingival distribution:
Widely distributed (Beck et al)
Efficacy of antibody response
IgG response are not able to control Pg (Lamster et al)
Rodenburg et al
-- Pg absent in younger age group (less than 20 yrs)
-- age 30 -70 yrs harbored 60% of pathogens
18. Horizontal transmission:
Siblings-
Petit et al 1993
Saarela et al 1996
Spouses –
Asikainen et al 1996:- 30-75%
Identical genotype
19. Route of infection from person to person
Saliva, mucosal contact and inanimate objects
20. VIRULENCE FACTORS
Classical studies
Recent observations
Molecules that result in the establishment and
maintenance of a species associated with or within
the confines of the host
Molecules that exerts a detrimental effect on a host cell
21.
22. Capsule
Anti-phagocytic virulence factor
Ruthenium red & routine lead acetate staining
Electron dense layer
Polysaccharide capsule
Some strains- devoid
6 distinct capsular serotypes (K1-K6)
Laine et al 1996
seventh serotype (K7) - R. E. Schifferle
23. Chemical composition:
Mansheim &
Kasper
• Galactose
• Glucose
• glucosamine
Okuda et al
• Rhamnose
• Glucose
• Galactose
• Mannose
• methylpentose
Schifferle et
al
• Absence of
galactose
• Amino sugars
24. Biological function:
More hydrophilic
Increased resistance to
- phagocytosis
- serum resistance
Decreased induction of PMN leukocyte
25. Schiffer et al- decreased ability to activate alternate
complement pathway
Sundqvist et al- capsule does not guarantee that specific
strains will be virulent
27. Mihara & Holt 1993:- 24-kDa
thymidine- fibroblasts. “fibroblast-activating factor”
Takahashi et al:- Bone assay- Ca++ release from bone
Watenabe et al:- 75kDa protein
B-cell activation, IL-1 production
28. Role in Coaggregation
Gibbons & Nygaard 1970- bacteria attach to both hard &
soft surfaces
G+ve & G-ve bacteria= specific outer membrane proteins
Pg & A. viscosus – initial event in formation of subgingival
biofilm
Kinder & Holt 1989 = specific adhesin- receptor molecule
29. P gingivalis & Hemin
hemin (iron) = growth
Karunakaran et al 1993 – 48 kDa & 18 kDa
Cytochrome b subunit
Fumarate Succinate ENERGY
Protoporphyrin IX Exogenous suppliment
Hemolysin Attack & Hemolyze RBC
30. GCF- hemoglobin
hemin-binding proteins – haptoglobin, hemopexin &
albumin
Shizukuishi et al – hemoglobin as main source of iron
31. Lipopolysaccharide
Larger molecules ranging from 10kDa & larger
Amphipathic character
Hydrophilic end-
Polysaccharide (O antigen)
Hydrophobic end- lipid A
SDS-PAGE analysis-
Ladder like band appearence
32. Endotoxicity – Lipid A (Ogawa et al 1993)
Immunobiological activity – O antigen (Takada H 1992)
33. P.gingivalis lipid A, induced
IL-1 receptor antagonist
IL-6, IL-8, interferon- γ
Granulocyte-macrophage colony-stimulating factor
Poor inducer of IL-lβ and TNF-α.
(Yamaji et al 1995, Ogawa et al )
34. P. gingivalis LPS, capable of stimulating the host
inflammatory response in the
epithelial cells,
endothelial cells,
fibroblasts,
macrophages etc
via the induction of host derived cytokine production.
35. Bacterial fimbriae
Fimbriae play important roles in the expression of
virulence
Peritrichous fashion
2 distinct fimbria molecules
LONG / MAJOR
Subunit Fim
protein SHORT/ MINOR
Subunit Mfa
fimA gene
mfa1 gene
36. Long/ Major fimbriae: (Yoshimura et al., 1984)
First recognized on outer surface from strain 381
FimA proteins – size 40.5 to 49 kDa
Type 1-4 based on amino-terminal sequence
37. Classification of Pg strains into different genetic groups
based on fimA variations: Amano A et al 1995
6 variants: Type I – V & Ib
Type II fimA genotype- Periodontitis (> 8 mm pockets)
Followed by type IV, Ib or I depending on ethnic population
type I & III – Healthy subjects
Fujise et al 2005 – despite lower prevalence, type I are
associated with diseased sites refractory to periodontal
treatment.
38. Adherence ability to host proteins:
Human salivary proteins- Statherin, Proline-rich proteins,
proline-rich glycoprotein
ECM- laminin, fibronectin, type I collagen, elastin,
vitronectin
Other bacterial components
39. Host cells:
Macrophages, fibroblasts, epithelial & endothelial cells
Interact with host components- α5β1-integrin, β2- integrin,
Inflammatory response:
release of cytokines like IL-1, IL-6, IL-8, and TNF-α, toll like
receptor 2 (Amano et al 1998, Ogawa et al 2002)
ICAM-1, VCAM-1, and P- and E-selectins,
α5β1
40. Short / Minor fimbriae: (Arai et al, 2000)
Homopolymers of subunit protein mfa1
Molecular mass 75 kDa
Visualized when long fimbriae are absent
Induce IL-1α, IL-1β, IL-6, TNF-α
41. Non fimbrial proteins
Regulate the expression of the fimbriae
Proteinase, Aminopeptidase, Caseinase, Collagenase etc
42. Proteinases
Earlier thought - non-specific degradation enzyme
Recent studies - cause specific activation/ inactivation of
bioactive proteins.
Exposed at the surface (in the outer membrane)- vesicles
Within the periplasmic space
43. Functions of proteases:
kuramitsu et al
Internally directed
Externally directed
Internally Externally
•Growth rate
•Outer membrane protein
processing
•Fimbrial expression
•Regulation of protease
expression
•Processing of proteases
•Vascular permeability
•Blood clotting
•Complement inactivation
•Hemagglutination
•Binding to eukaryotic cells
•Binding to G+ve bacteria
•MMP activation
•Platelet aggregation
•Cytokine regulation
•Antibody degradation
•Cytokine receptor alterations
•Attenuate neutrophil activity
45. Collagenase
Periodontal tissue destruction - specific proteolytic
enzymes, especially the collagenases
Host and periodontopathic microbiota
P. gingivalis collagenase may participate with host-derived
collagenase (Mayrand and Grenier et al 1985)
46. Aminopeptidase
Only member of periodontopathic microbiota that exhibits
strong dipeptidyl arylaminopeptidase activity
Acts on type I collagen
2 additional aminopeptidase Abiko et al
N-CBz-glycyl-arginyl peptidase
Glycyl-prolyl peptidase
53. Activation of kallikrein/Kinin system
Hinode et al.(1992)and Kaminishi et al.(1993) ;
Imamura et al.(1994)
Potent vascular permeability enhancement (VPE) factors
GCF production and edema formation continuous
supply of nutrients.
Bradykinin - Alveolar bone resorption by inducing
prostaglandin production
Gingipain R
Gingipain K
55. Activation of blood clotting mechanism
Potent platelet activator and converts fibrinogen to a fibrin
clot, thus plugging damaged vessels.
Enhances vascular permeability (DeMichele et al 1990)
Induces leukocyte chemotaxis (Bar- Shavit et al 1983)
56. Stimulates prostaglandin secretion by osteoblastic cells &
potentiates LPS-stimulated IL- 1 production by
macrophages
HRgpA was more potent than RgpB
Gingipain R
58. Degradation of fibrinogen & fibrin
Bleeding on probing
Gingipains degraded fibrinogen within minutes (Pike et al 1996)
Fibrinogenolytic activity of the bacterium is attributed
mainly to the Kgp
Cannot be effectively controlled by host proteinase
inhibitors
Gingipain R
Gingipain K
59. Disturbance of host defence system
Gingipain R
complement system
activation
C3 convertase
production
bacteriolysis through
complement system
activation impaired
consumption of its
components
70. Temperature
Mean temperature of the gingival sulcus during health -
35°C (30°C to 38°C ) Socransky SS, Haffajee AD, 1991
P. gingivalis when exposed to elevated temperature - heat
shock response Lu et al 1994
Heat shock proteins function as molecular chaperones -
involved in protein folding and oligomerization of
structural proteins and DNA replication
71. GroEL (HSP6O family) and DnaK (HSP70 family)
homologs have been described in P. gingivalis
Vayssier et al 1994
temperature - fimbrillin expression
superoxide dismutase activity
Amano et al 1994
72. pH
pH range within gingival sulcus during health -7.0 to 8.5
(Cimasoni 1983)
As disease progresses
Periodontal pockets deepen
and host inflammatory response is induced
pH increases (Cimasoni 1985)
Gram +ve facultative →Gram –ve anaerobic
(Marsh et al 1994)
73. Optimal pH for P. gingivalis - 7.5 (7.5 to 8.5)
Marsh et al 1994
Trypsin-like activity with pH
79. INTERACTIONS WITH EPITHELIAL CELLS
Gingival epithelium- stratified squamous epithelium
Junctional epithelium
Sulcular epithelium
Interaction- bacteria & epithelial cells
CELLULAR MICROBIOLOGY (Cossart et al 1996)
Invasion- primary cultures of gingival epithelial cells, oral
epithelial cell lines & cultures of multilayered pocket
epithelium
NON KERATINIZED
80.
81.
82. Impact on bone metabolism
Alveolar bone loss- stimulating bone resorption, inducing
bone destruction & inhibiting bone formation
Pg LPS
Osteoclasts
PGE2 IL-1β, TNF α
Alveolar bone resorption
Macrophages, monocytes
fibroblasts
88. EFFECT ON PERIODONTAL TREATMENT
Scaling and root planing - temporary decrease in levels but
not capable of eradicating the organism from subgingival
sites.
Non - resective periodontal surgery - not effective in
removing P. gingivalis
89. Elimination of periodontal pockets along with proper oral
hygiene (Mombelli A, 1995)
Systemic antibiotic therapy + scaling and root planing may
not ensure subgingival eradication of P. gingivalis
Topical antimicrobial therapy - not very useful
90. Periodontal surgery + systemic antibiotic therapy + good
oral hygiene:
Zarkesh et al. (1999) – coating PTFE barrier membranes
with tetracycline
They permitted less P. gingivalis colonization and more
clinical attachment gain
96. Questions regarding Pg mediated mechanisms in
vascular disease
How can Pg, an obligate anaerobic bacterium, safely travel
through the bloodstream from small vessels in the oral cavity to
reach the central arteries in which atherosclerotic lesions
develop?
How can Pg adhere to normal endothelial cells given the
extremely rapid blood flow in the abdominal or thoracic aorta?
How can Pg invade normal endothelial cells of large-sized
arteries?
97. Under normal physiologic conditions, not possible for
anaerobic bacterium to invade normal endothelial cells
An indirect mechanism
However
Direct invasion – endothelial function/ structure is
destroyed Hokamura et al 2009
101. Attenuated and inactivated bacterial vaccines
Production of serum antibody, which correlated with
immune protection from the virulence properties of
P.gingivalis (Ebersole 1997, Genco CA, 1992,
Kesavalu,1992)
Active immunization of mice (Baker et al 1997) or rats
(Taubman et al 1983) with P. gingivalis - ability to alter
disease manifestations of periodontitis in these animals
102. Live bacterial vectors
The hemagglutinin gene of P. gingivalis has been cloned
into an avirulent strains of S. typhimurium
Dusek DM 1995
Used to orally immunize mice and resulted in a systemic
and mucosal response to this antigen
103. Passive immunization
Booth et al. (1996) produced a murine monoclonal
antibody to P. gingivalis which prevented recolonization of
deep pockets in periodontitis patients
Laboratory tests revealed that this antibody inhibited the
hemagglutination of red blood cells
104. Purified antigen (subunit) vaccines
Bird et al. (1995) used the mouse abscess model and
immunized it with an outer membrane – induction of
protective immunity
105. Synthetic antigen vaccines
Requires synthesis of linear & branched polymers of 3-10
amino acids based on known sequences of microbial
antigens.
Weakly immunogenic
Coupled to large proteins antibody response
Safe, cheap, easy to store & handle & ideally suited to
specific targets
107. REFERENCES
Ingar Olsen, Haroun Shah & Saheer Gharbia. Taxonomy
and biochemical characteristics of Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis.
Periodontology 2000, Vol. 20, 1999, 14-52
Jorgen Slots. Actinobacillus actinomycetemcomitans and
Porphyromonas gingivalis in periodontal disease: introduction.
Periodontology 2000, Vol. 20, 1999, 7-13
Sigmund Socransky and Haffajee. Periodontal microbial
ecology. Periodontology 2000; Vol 38, 2005, 135-187
108. Stanley Holt, Lakshmyya Kaesavalu, Stephen Walker &
C.A. Genco. Virulence factors of Porphyromonas gingivalis.
Periodontology 2000, Vol. 20, 1999, 168-238
Takahisa Imamura. The role of gingipains in the pathogenesis
of periodontal diseases. J Periodontol 2003;74:111-118
Newman, Takei, Klokkevold, Carranza. 10th edition. Carranza’s
Clinical Periodontology. W. B. Saunders Company
H.k.Kuramitsu. Proteases of Porphyromonas gingivalis: what
don’t they do?. Oral Microbiol Immunol 1998:13:263-270
109. Jorgen Slots & Miriam Ting. Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis in
human periodontal disease: occurrence and treatment.
Periodontology 2000, Vol. 20, 1999, 82-121
Arie J. Van Winkelhoff & Jorgen Slots. Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis in non
oral infections. Periodontology 2000, Vol. 20, 1999, 122-135
Jorgen Slots & Taubman. Contemporary Oral Microbiology &
Immunolgy
110. Richard Lamont & Howard Jenkinson. Life below the gum
line: Pathogenic mechanisms of porphyromonas gingivalis.
Microbiol. Mol. Biol. Rev. 1998, 62(4):1244
Koichiro Wada & Yoshinori kamisaki. Molecular dissection
of porphyromonas gingivalis- related to arteriosclerosis: a novel
mechanism of vascular disease. Periodontology 2000, Vol 54,
2010, 222-234
Denis Kinane, John Mooney & Jeffrey Ebersol.
Humoral immune response to Actinobacillus
actinomycetemcomitans and Porphyromonas gingivalis
in periodontal disease. Periodontology 2000, Vol. 20, 1999,
289-340
Notas del editor
Nonbacterial microorganisms =Mycoplasma species, yeasts, protozoa, and viruses.
As periodontal pathogens
Ristella melaninogenica
Carbohydrate fermenters
Genus porphyromonas was chosen for
Currently include
The genus Porphyromonas now comprises 12 pigmented species, but recently Oribaculum catoniae, a non-pigmented and saccharolytic taxon, was shown to constitute a new species of the genus Porphyromonas. The inclusion of Porphyromonas catoniae in the genus has necessitated an emended description of the genus Porphyromonas to include both non-pigmented and saccharolytic species.